MoonLake Immunotherapeutics (MLTX)
39.74
-1.12
(-2.74%)
USD |
NASDAQ |
May 17, 16:00
39.74
0.00 (0.00%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Return Level: 39.75 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 39.75 |
May 16, 2024 | 40.86 |
May 15, 2024 | 40.69 |
May 14, 2024 | 40.77 |
May 13, 2024 | 41.71 |
May 10, 2024 | 40.92 |
May 09, 2024 | 41.97 |
May 08, 2024 | 42.63 |
May 07, 2024 | 43.66 |
May 06, 2024 | 44.52 |
May 03, 2024 | 45.26 |
May 02, 2024 | 42.57 |
May 01, 2024 | 42.84 |
April 30, 2024 | 40.91 |
April 29, 2024 | 41.77 |
April 26, 2024 | 42.49 |
April 25, 2024 | 42.25 |
April 24, 2024 | 42.43 |
April 23, 2024 | 43.25 |
April 22, 2024 | 41.02 |
April 19, 2024 | 42.19 |
April 18, 2024 | 42.25 |
April 17, 2024 | 43.51 |
April 16, 2024 | 43.50 |
April 15, 2024 | 43.64 |
Date | Value |
---|---|
April 12, 2024 | 43.91 |
April 11, 2024 | 45.65 |
April 10, 2024 | 46.18 |
April 09, 2024 | 46.75 |
April 08, 2024 | 46.27 |
April 05, 2024 | 47.17 |
April 04, 2024 | 45.99 |
April 03, 2024 | 45.97 |
April 02, 2024 | 47.25 |
April 01, 2024 | 48.60 |
March 28, 2024 | 50.23 |
March 27, 2024 | 50.21 |
March 26, 2024 | 50.08 |
March 25, 2024 | 51.74 |
March 22, 2024 | 52.00 |
March 21, 2024 | 52.37 |
March 20, 2024 | 49.50 |
March 19, 2024 | 50.59 |
March 18, 2024 | 48.56 |
March 15, 2024 | 47.25 |
March 14, 2024 | 43.78 |
March 13, 2024 | 44.90 |
March 12, 2024 | 46.04 |
March 11, 2024 | 47.05 |
March 08, 2024 | 45.61 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
4.69
Minimum
May 16 2022
63.86
Maximum
Feb 12 2024
21.56
Average
10.36
Median
Total Return Level Benchmarks
Qiagen NV | 47.03 |
LENZ Therapeutics Inc | 16.35 |
AC Immune SA | 3.18 |
CRISPR Therapeutics AG | 56.22 |
Addex Therapeutics Ltd | 8.79 |